Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaxi Pharmaceutical, a subsidiary of China Resources Sanjiu, is a prominent Chinese pharmaceutical company specializing in Traditional Chinese Medicine (TCM). Founded in 1955 and headquartered in Zhongshan, Guangdong, the company is best known for its Shaxi Liangcha (Shaxi Herbal Tea), which is recognized as a national intangible cultural heritage in China. The company's product portfolio includes a variety of over-the-counter TCM formulations such as granules, tablets, and syrups primarily targeting respiratory and digestive health. Shaxi Pharmaceutical operates modern GMP-certified manufacturing facilities and benefits from the extensive commercial network of the China Resources Group. It remains a leading brand in the Lingnan region, focusing on the modernization and standardization of traditional herbal remedies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广东沙溪制药.